Amicus Therapeutics, Inc. (FOLD)

CIK 1178879 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Amicus Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 12, 2026SCHEDULE 13G/A0000886982-26-000443
May 14, 2026SCHEDULE 13G0000312069-26-000177
May 11, 2026SCHEDULE 13G0000886982-26-000166
May 7, 2026SCHEDULE 13G0001610520-26-000058
May 7, 202615-12G0001140361-26-019442
May 1, 2026SCHEDULE 13G0001076809-26-000040
Apr 29, 2026EFFECT9999999995-26-001364
Apr 29, 2026EFFECT9999999995-26-001369
Apr 29, 2026EFFECT9999999995-26-001366
Apr 29, 2026EFFECT9999999995-26-001363
Apr 29, 2026EFFECT9999999995-26-001365
Apr 29, 2026SCHEDULE 13G0002100119-26-000176
Apr 29, 2026EFFECT9999999995-26-001367
Apr 29, 2026EFFECT9999999995-26-001368
Apr 29, 2026EFFECT9999999995-26-001370
Apr 27, 2026POSASR0001140361-26-016941
Apr 27, 2026POSASR0001140361-26-016944
Apr 27, 2026S-8 POS0001140361-26-016897
Apr 27, 2026POSASR0001140361-26-016942
Apr 27, 2026POS AM0001140361-26-016982
Apr 27, 2026S-8 POS0001140361-26-016902
Apr 27, 2026S-8 POS0001140361-26-016907
Apr 27, 2026POSASR0001140361-26-016946
Apr 27, 2026POS AM0001140361-26-016984
Apr 27, 202640001193125-26-182285